Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.
Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...
Scott Tagawa, MD, highlights the PSMAddition trial's promising results, showcasing Lutetium-177 PSMA-617's significant ...
Among patients with prostate cancer with homologous recombination repair mutations (HRRm) receiving Akeega (niraparib and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback